Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1979 4
1980 2
1981 1
1982 4
1983 4
1984 8
1985 13
1986 13
1987 19
1988 22
1989 74
1990 49
1991 56
1992 100
1993 111
1994 132
1995 145
1996 178
1997 215
1998 209
1999 243
2000 231
2001 254
2002 277
2003 318
2004 329
2005 280
2006 333
2007 321
2008 290
2009 258
2010 272
2011 249
2012 243
2013 242
2014 227
2015 251
2016 205
2017 183
2018 190
2019 164
2020 191
2021 183
2022 199
2023 168
2024 179
2025 246
2026 180
2027 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,420 results

Results by year

Filters applied: . Clear all
Page 1
Paroxetine.
Tang SW, Helmeste D. Tang SW, et al. Expert Opin Pharmacother. 2008 Apr;9(5):787-94. doi: 10.1517/14656566.9.5.787. Expert Opin Pharmacother. 2008. PMID: 18345955 Review.
BACKGROUND: Paroxetine is a widely used antidepressant that has received attention regarding suicide risk in younger patients. ...RESULTS/CONCLUSION: Paroxetine is a serotonin re-uptake inhibitor with good selectivity and no significant active metabolites. ...
BACKGROUND: Paroxetine is a widely used antidepressant that has received attention regarding suicide risk in younger patients. ...RES …
Paroxetine Attenuates Chondrocyte Pyroptosis and Inhibits Osteoclast Formation by Inhibiting NF-kappaB Pathway Activation to Delay Osteoarthritis Progression.
Zheng X, Qiu J, Gao N, Jiang T, Li Z, Zhang W, Gong Y, Hong Z, Hong H. Zheng X, et al. Drug Des Devel Ther. 2023 Aug 16;17:2383-2399. doi: 10.2147/DDDT.S417598. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 37605762 Free PMC article.
To investigate the role of paroxetine in vivo, we constructed a mouse model with destabilization of the medial meniscus (DMM) surgery. ...Additionally, the formation of osteoclasts in the subchondral bone was reduced in the paroxetine-treated mice. Further analysis …
To investigate the role of paroxetine in vivo, we constructed a mouse model with destabilization of the medial meniscus (DMM) surgery …
Paroxetine: a review.
Bourin M, Chue P, Guillon Y. Bourin M, et al. CNS Drug Rev. 2001 Spring;7(1):25-47. doi: 10.1111/j.1527-3458.2001.tb00189.x. CNS Drug Rev. 2001. PMID: 11420571 Free PMC article. Review.
Paroxetine is a potent and selective serotonin reuptake inhibitor (SSRI) with currently approved indications for the treatment of depression, obsessive-compulsive disorder, panic disorder and social phobia. ...Paroxetine exhibits some affinity for the muscarinic cho …
Paroxetine is a potent and selective serotonin reuptake inhibitor (SSRI) with currently approved indications for the treatment of dep …
Neuropharmacology of paroxetine.
Nemeroff CB, Owens MJ. Nemeroff CB, et al. Psychopharmacol Bull. 2003 Spring;37 Suppl 1:8-18. Psychopharmacol Bull. 2003. PMID: 14566196 Review.
The in vivo pharmacologic properties of paroxetine are well characterized, especially following acute administration. However, the pharmacologic effects of chronically administered paroxetine remain an active area of study. ...At usual clinical doses (ie, 20 mg/d), …
The in vivo pharmacologic properties of paroxetine are well characterized, especially following acute administration. However, the ph …
Paroxetine hydrochloride.
Germann D, Ma G, Han F, Tikhomirova A. Germann D, et al. Profiles Drug Subst Excip Relat Methodol. 2013;38:367-406. doi: 10.1016/B978-0-12-407691-4.00008-3. Profiles Drug Subst Excip Relat Methodol. 2013. PMID: 23668408 Review.
Paroxetine hydrochloride (3S-trans)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-piperidine hydrochloride (or (-)-(3S,4R)-(4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)-phenoxy]methyl]piperidine hydrochloride), a phenylpiperidine derivative, is a selective serotoni …
Paroxetine hydrochloride (3S-trans)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-piperidine hydrochloride (or (-)-(3S,4R)-( …
Paroxetine controlled release.
Bang LM, Keating GM. Bang LM, et al. CNS Drugs. 2004;18(6):355-64; discussion 365-6. doi: 10.2165/00023210-200418060-00003. CNS Drugs. 2004. PMID: 15089103 Review.
A controlled-release (CR) formulation of the SSRI paroxetine has been developed. This CR formulation delays the release of paroxetine until the tablet has passed through the stomach; the drug is then released over 4-5 hours. ...Paroxetine CR was generally wel …
A controlled-release (CR) formulation of the SSRI paroxetine has been developed. This CR formulation delays the release of paroxet …
An overview of paroxetine.
Boyer WF, Feighner JP. Boyer WF, et al. J Clin Psychiatry. 1992 Feb;53 Suppl:3-6. J Clin Psychiatry. 1992. PMID: 1531819 Review.
As with other SSRIs, there are few clinically significant drug interactions with paroxetine. Clinical studies consistently show that paroxetine alleviates moderate or severe depression and associated anxiety. ...Unlike other SSRIs, paroxetine has a relatively …
As with other SSRIs, there are few clinically significant drug interactions with paroxetine. Clinical studies consistently show that …
Focus on paroxetine.
Green B. Green B. Curr Med Res Opin. 2003;19(1):13-21. doi: 10.1185/030079902125001353. Curr Med Res Opin. 2003. PMID: 12661775 Review.
This review of paroxetine is based on Medline and PsycLit searches and a manual search of the available research literature. It aims to cover the pharmacology of this frequently prescribed SSRI antidepressant in terms of its indications, efficacy and adverse effects. Overa …
This review of paroxetine is based on Medline and PsycLit searches and a manual search of the available research literature. It aims …
Paroxetine-induced enuresis.
Toros F, Erdoğan K. Toros F, et al. Eur Psychiatry. 2003 Feb;18(1):43-4. doi: 10.1016/s0924-9338(02)00010-x. Eur Psychiatry. 2003. PMID: 12648899 No abstract available.
Paroxetine: safety and tolerability issues.
Marks DM, Park MH, Ham BJ, Han C, Patkar AA, Masand PS, Pae CU. Marks DM, et al. Expert Opin Drug Saf. 2008 Nov;7(6):783-94. doi: 10.1517/14740330802423168. Expert Opin Drug Saf. 2008. PMID: 18983224 Review.
Paroxetine is the most potent inhibitor of serotonin re-uptake among the now available SSRIs. ...Paroxetine and paroxetine CR are not indicated for use in the paediatric population and are categorised as Pregnancy Class D. ...
Paroxetine is the most potent inhibitor of serotonin re-uptake among the now available SSRIs. ...Paroxetine and paroxetine …
7,420 results